Compare Stocks

Date Range: 

 Burcon NutraScienceSigilon TherapeuticsAptose BiosciencesErgomedBiotest Aktiengesellschaft
SymbolTSE:BUNASDAQ:SGTXTSE:APSLON:ERGOETR:BIO
Price Information
Current PriceC$4.50$13.49C$6.04GBX 1,350€29.00
52 Week RangeBuyBuyBuyN/AN/A
MarketRank™
Overall Score1.41.41.30.60.5
Analysis Score2.53.43.50.00.0
Community Score2.63.02.83.12.3
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.00.00.0
Earnings & Valuation Score0.00.60.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/AN/A
Consensus Price TargetC$5.00$53.75C$12.00N/AN/A
% Upside from Price Target11.11% upside298.44% upside98.68% upsideN/AN/A
Trade Information
Market CapC$481.95 million$425.33 millionC$537.22 million£658.13 million$573.79 million
BetaN/AN/AN/AN/AN/A
Average Volume509,937118,10256,483109,7811,927
Sales & Book Value
Annual RevenueC$12,045.00N/AN/A£86.39 million$484.20 million
Price / Sales40,012.83N/AN/A7.621.19
CashflowC$0.11 per shareN/AC$1.21 per shareGBX 36.72 per share€2.12 per share
Price / Cash41.96N/A5.0136.7613.68
Book ValueC$0.33 per shareN/AC$1.34 per shareGBX 108.20 per share€11.16 per share
Price / Book13.80N/AN/A0.122.60
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC$0.00N/AC($0.83)GBX 19.20(€0.80)
Trailing P/E Ratio4,500.000.00N/A70.31N/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/A€0.04
Dividend YieldN/AN/AN/AN/A0.14%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.13%N/A0.90%9.66%106.52%
Current Ratio12.61%N/A18.36%1.39%5.27%
Quick Ratio12.21%N/A17.97%1.35%2.49%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees2199311,1501,928
Shares Outstanding107.10 million31.53 million88.94 million48.75 million19.79 million
Next Earnings Date7/5/2021 (Estimated)6/17/2021 (Estimated)8/3/2021 (Estimated)N/A5/11/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable
SourceHeadline
Biotest Aktiengesellschaft (ETR:BIO) Trading Down 3.4%Biotest Aktiengesellschaft (ETR:BIO) Trading Down 3.4%
americanbankingnews.com - April 21 at 12:14 AM
Epazz, Inc.: Epazz DeskFlex Room Scheduling Software Launches Vaccine Management Solution as Part of COVID-19 Vaccination InitiativesEpazz, Inc.: Epazz DeskFlex Room Scheduling Software Launches Vaccine Management Solution as Part of COVID-19 Vaccination Initiatives
finanztreff.de - March 31 at 4:49 AM
BIOTEST AG ST O.N. (BIO.MU)BIOTEST AG ST O.N. (BIO.MU)
in.finance.yahoo.com - October 13 at 4:58 PM
Takeda-Led Group Begins Manufacturing COVID-19 Plasma Treatment, Says Confident Of EfficacyTakeda-Led Group Begins Manufacturing COVID-19 Plasma Treatment, Says Confident Of Efficacy
benzinga.com - October 13 at 3:50 AM
BIOTEST AG ST O.N. (BIO.DU)BIOTEST AG ST O.N. (BIO.DU)
au.finance.yahoo.com - October 12 at 4:04 PM
BIOTEST AG STAMMAKTIEN O.N. (BIO.SG)BIOTEST AG STAMMAKTIEN O.N. (BIO.SG)
au.finance.yahoo.com - October 9 at 7:15 PM
Biotest Says Talks With Private Equity Investor at Early StageBiotest Says Talks With Private Equity Investor at Early Stage
bloomberg.com - October 4 at 6:22 PM
Veevas Vault eTMF Gets Implemented by Biotest for TrialsVeeva's Vault eTMF Gets Implemented by Biotest for Trials
nasdaq.com - October 2 at 1:23 PM
Triton Said to Pursue Stake in Creat’s Blood Plasma Unit BiotestTriton Said to Pursue Stake in Creat’s Blood Plasma Unit Biotest
msn.com - October 2 at 1:23 PM
Pneumonia Therapeutics Market 2020 Top Leading Players, Gross Margin Analysis, Size, Market Share, Trends, Types to 2026Pneumonia Therapeutics Market 2020 Top Leading Players, Gross Margin Analysis, Size, Market Share, Trends, Types to 2026
marketwatch.com - September 14 at 7:52 AM
Coronavirus Testing Kits Market May Expand Rapidly Post 2020 | MyLab, BioMednomics, Getein Biotech, WondfoCoronavirus Testing Kits Market May Expand Rapidly Post 2020 | MyLab, BioMednomics, Getein Biotech, Wondfo
bignewsnetwork.com - September 4 at 10:17 AM
Biotest: Wer hätte das gedacht?Biotest: Wer hätte das gedacht?
aktiencheck.de - August 24 at 2:48 PM
Biotech Report: Biotest (BIO3) klettern deutlich, MorphoSys (MOR) konsolidierenBiotech Report: Biotest (BIO3) klettern deutlich, MorphoSys (MOR) konsolidieren
finanznachrichten.de - August 24 at 2:48 PM
Liver Disease Treatment Market 2020 Share, Size, Regional Trend, Top Manufacturers, Future Growth, Types and Applications, Forecast to 2025Liver Disease Treatment Market 2020 Share, Size, Regional Trend, Top Manufacturers, Future Growth, Types and Applications, Forecast to 2025
marketwatch.com - August 19 at 8:49 AM
Biotest Aktiengesellschaft (0N70.L)Biotest Aktiengesellschaft (0N70.L)
uk.finance.yahoo.com - August 16 at 5:11 AM
Asthma Preventive Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2026Asthma Preventive Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2026
marketwatch.com - August 14 at 4:11 AM
Plasma Therapy Global Market Report 2020-30: Covid 19 Growth and ChangePlasma Therapy Global Market Report 2020-30: Covid 19 Growth and Change
finance.yahoo.com - July 30 at 12:34 PM
Asthma Preventive Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2024Asthma Preventive Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2024
www.marketwatch.com - July 30 at 7:34 AM
Biotest AG: Biotest presented promising data on next generation recombinant Factor VIII at ISTH 2020Biotest AG: Biotest presented promising data on next generation recombinant Factor VIII at ISTH 2020
uk.finance.yahoo.com - July 21 at 11:47 PM
Plasma Therapy Market: Comprehensive study explores Huge Growth in FuturePlasma Therapy Market: Comprehensive study explores Huge Growth in Future
www.bignewsnetwork.com - July 20 at 2:09 PM
Biotest AG: Biotest Supervisory Board extends contracts with the Board of ManagementBiotest AG: Biotest Supervisory Board extends contracts with the Board of Management
uk.finance.yahoo.com - July 20 at 8:26 AM
PRESS RELEASE: Biotest AG: Biotest submits phase II study with trimodulin for the treatment of severe COVID-19 patientsPRESS RELEASE: Biotest AG: Biotest submits phase II study with trimodulin for the treatment of severe COVID-19 patients
www.finanztreff.de - July 16 at 9:07 AM
Coagulation Factor Deficiency Pipeline Insights Report, 2020 Featuring Sanofi, AryoGen Pharmed Co, Biotest, ICON, and Roche - ResearchAndMarkets.comCoagulation Factor Deficiency Pipeline Insights Report, 2020 Featuring Sanofi, AryoGen Pharmed Co, Biotest, ICON, and Roche - ResearchAndMarkets.com
www.businesswire.com - July 3 at 7:37 AM
Polygon applies for authorization to convene an extraordinary general meeting of Biotest AGPolygon applies for authorization to convene an extraordinary general meeting of Biotest AG
markets.businessinsider.com - July 1 at 7:55 AM
Pneumonia Therapeutics Market - Current Impact to Make Massive Changes | GlaxoSmithKline, Merck & Co, Novartis, PfizerPneumonia Therapeutics Market - Current Impact to Make Massive Changes | GlaxoSmithKline, Merck & Co, Novartis, Pfizer
www.bignewsnetwork.com - June 30 at 9:39 AM
DateCompanyBrokerageAction
2/18/2021Burcon NutraScienceCanaccord GenuityBoost Price Target
8/31/2020Burcon NutraScienceEight CapitalBoost Price Target
8/28/2020Burcon NutraScienceBeacon SecuritiesReiterated Rating
12/29/2020Sigilon TherapeuticsBarclaysInitiated Coverage
12/29/2020Sigilon TherapeuticsMorgan StanleyInitiated Coverage
12/29/2020Sigilon TherapeuticsJefferies Financial GroupInitiated Coverage
10/19/2020Aptose BiosciencesCantor FitzgeraldReiterated Rating
9/22/2020Aptose BiosciencesAlliance Global PartnersReiterated Rating
5/23/2019Aptose BiosciencesRoth CapitalReiterated Rating
3/1/2019Aptose BiosciencesRoyal Bank of CanadaReiterated Rating
12/3/2018Aptose BiosciencesHC WainwrightReiterated Rating
11/16/2018Aptose BiosciencesB. RileyReiterated Rating
1/26/2021ErgomedShore CapitalReiterated Rating
6/13/2019ErgomedNumis SecuritiesReiterated Rating
8/15/2018Biotest AktiengesellschaftequinetSet Price Target
(Data available from 5/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.